192 related articles for article (PubMed ID: 19912643)
1. Hypermethylation of the DLC1 CpG island does not alter gene expression in canine lymphoma.
Bryan JN; Jabbes M; Berent LM; Arthur GL; Taylor KH; Rissetto KC; Henry CJ; Rahmatpanah F; Rankin WV; Villamil JA; Lewis MR; Caldwell CW
BMC Genet; 2009 Nov; 10():73. PubMed ID: 19912643
[TBL] [Abstract][Full Text] [Related]
2. Hypermethylation of the death-associated protein kinase CpG island in canine B-cell lymphoid tumors.
Sato M; Mochizuki H; Goto-Koshino Y; Fujiwara-Igarashi A; Takahashi M; Fujino Y; Ohno K; Tsujimoto H
Vet Immunol Immunopathol; 2014 Oct; 161(3-4):222-31. PubMed ID: 25193469
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.
Shi H; Guo J; Duff DJ; Rahmatpanah F; Chitima-Matsiga R; Al-Kuhlani M; Taylor KH; Sjahputera O; Andreski M; Wooldridge JE; Caldwell CW
Carcinogenesis; 2007 Jan; 28(1):60-70. PubMed ID: 16774933
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of p16 tumor suppressor gene expression via promoter hypermethylation in canine lymphoid tumor cells.
Fujiwara-Igarashi A; Goto-Koshino Y; Mochizuki H; Sato M; Fujino Y; Ohno K; Tsujimoto H
Res Vet Sci; 2014 Aug; 97(1):60-3. PubMed ID: 24815345
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of hypermethylation of death-associated protein kinase (DAPK) gene CpG island in dogs with high-grade B-cell lymphoma.
Sato M; Mochizuki H; Goto-Koshino Y; Fujiwara-Igarashi A; Takahashi M; Ohno K; Tsujimoto H
Vet Comp Oncol; 2018 Sep; 16(3):409-415. PubMed ID: 29527805
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic silencing of the 3p22 tumor suppressor DLEC1 by promoter CpG methylation in non-Hodgkin and Hodgkin lymphomas.
Wang Z; Li L; Su X; Gao Z; Srivastava G; Murray PG; Ambinder R; Tao Q
J Transl Med; 2012 Oct; 10():209. PubMed ID: 23050586
[TBL] [Abstract][Full Text] [Related]
7. Aberrant DNA methylation of alternative promoter of DLC1 isoform 1 in meningiomas.
Bujko M; Kober P; Rusetska N; Wakuła M; Goryca K; Grecka E; Matyja E; Neska J; Mandat T; Bonicki W; Siedlecki JA
J Neurooncol; 2016 Dec; 130(3):473-484. PubMed ID: 27614886
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic silencing of TFPI-2 in canine diffuse large B-cell lymphoma.
Ferraresso S; Bresolin S; Aricò A; Comazzi S; Gelain ME; Riondato F; Bargelloni L; Marconato L; Kronnie Gt; Aresu L
PLoS One; 2014; 9(4):e92707. PubMed ID: 24695110
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73.
van Doorn R; Zoutman WH; Dijkman R; de Menezes RX; Commandeur S; Mulder AA; van der Velden PA; Vermeer MH; Willemze R; Yan PS; Huang TH; Tensen CP
J Clin Oncol; 2005 Jun; 23(17):3886-96. PubMed ID: 15897551
[TBL] [Abstract][Full Text] [Related]
10. Promoter methylation of the DLC‑1 gene and its inhibitory effect on human colon cancer.
Dai Z; Jin Y
Oncol Rep; 2013 Sep; 30(3):1511-7. PubMed ID: 23783552
[TBL] [Abstract][Full Text] [Related]
11. Tumor-specific methylation of the 8p22 tumor suppressor gene DLC1 is an epigenetic biomarker for Hodgkin, nasal NK/T-cell and other types of lymphomas.
Ying J; Li H; Murray P; Gao Z; Chen YW; Wang Y; Lee KY; Chan AT; Ambinder RF; Srivastava G; Tao Q
Epigenetics; 2007; 2(1):15-21. PubMed ID: 17965626
[TBL] [Abstract][Full Text] [Related]
12. Methylation of promoter region in p27 gene plays a role in the development of lymphoid malignancies.
Nakatsuka S; Liu A; Yao M; Takakuwa T; Tomita Y; Hoshida Y; Nishiu M; Aozasa K
Int J Oncol; 2003 Mar; 22(3):561-8. PubMed ID: 12579309
[TBL] [Abstract][Full Text] [Related]
13. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic regulation of CD44 in Hodgkin and non-Hodgkin lymphoma.
Eberth S; Schneider B; Rosenwald A; Hartmann EM; Romani J; Zaborski M; Siebert R; Drexler HG; Quentmeier H
BMC Cancer; 2010 Sep; 10():517. PubMed ID: 20920234
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic Silencing of Tumor Suppressor lncRNA
Zhang MY; Calin G; Deng MD; Au-Yeung RKH; Wang LQ; Chim CS
Genes (Basel); 2022 Jan; 13(1):. PubMed ID: 35052468
[TBL] [Abstract][Full Text] [Related]
16. Frequent epigenetic inactivation of the RASSF1A tumor suppressor gene in Hodgkin's lymphoma.
Murray PG; Qiu GH; Fu L; Waites ER; Srivastava G; Heys D; Agathanggelou A; Latif F; Grundy RG; Mann JR; Starczynski J; Crocker J; Parkes SE; Ambinder RF; Young LS; Tao Q
Oncogene; 2004 Feb; 23(6):1326-31. PubMed ID: 14961078
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylation of a 5' CpG island of p16 is a frequent event in non-Hodgkin's lymphoma.
Martinez-Delgado B; Fernandez-Piqueras J; Garcia MJ; Arranz E; Gallego J; Rivas C; Robledo M; Benitez J
Leukemia; 1997 Mar; 11(3):425-8. PubMed ID: 9067584
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic changes in the DAP-kinase CpG island in pediatric lymphoma.
Shiramizu B; Mick P
Med Pediatr Oncol; 2003 Dec; 41(6):527-31. PubMed ID: 14595709
[TBL] [Abstract][Full Text] [Related]
19. Frequent Downregulation and Promoter Hypermethylation of DLC1: Relationship with Clinical Outcome in Gallbladder Cancer.
Singh D; Bharti A; Biswas D; Tewari M; Kar AG; Ansari MA; Singh S; Narayan G
J Gastrointest Cancer; 2022 Jun; 53(2):237-244. PubMed ID: 33417200
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of DNA methylation profiles of the CpG island of the ABCB1 gene in dogs with lymphoma.
Tomiyasu H; Fujiwara-Igarashi A; Goto-Koshino Y; Fujino Y; Ohno K; Tsujimoto H
Am J Vet Res; 2014 Sep; 75(9):835-41. PubMed ID: 25157887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]